UBRELVY & DESIGN

Class [005]
Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, facial asymmetries and defects and conditions of the human skin, namely stretch marks, birthmarks, scarring, volume loss, and skin pigmentation diseases and disorders, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; pharmaceutical preparations for the treatment of neurological disorders, namely Huntington's Disease, brain injury, spinal cord injury and seizure disorders, muscle dystonia, smooth muscle disorders, disorders of the autonomic nervous system, headaches, hyperhidrosis, sports injuries, namely fractures, sprains, cartilage injuries, dislocated joints and muscle soreness, cerebral palsy, muscle spasms, muscle tremors caused by Huntington's Disease, brain injury, spinal cord injury and seizure disorders and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth and pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing pharmaceutical preparations; pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; pharmaceutical preparations and medicines for the treatment of sensory organ disorders, namely ophthalmological diseases and disorders, ocular disorders, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, dermatitis, skin pigmentation diseases, pharmaceutical preparations for the treatment of skin irritations, sunburn, rashes, and acne; pharmaceutical preparations and medicines for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease; pharmaceutical preparations and medicines for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations and medicines for the treatment of circulatory system disorders; pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders, namely dermatitis, skin pigmentation diseases, eczema, psoriasis and rosacea; pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage and promote bone strength and bone health and which are used in the treatment of bone disorders and bone diseases; antibiotics; antifungal preparations; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative nerve diseases and disorders, namely multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy, brain injury, spinal cord injury, seizure disorders, dementia; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely diabetic neuropathy, Guillain-Barré syndrome, acute motor axonal neuropathy, botulism, Charcot-Marie-Tooth disease, leprosy; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism; pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body used in connection with anti-aging, namely for use in the treatment of glabellar lines, facial wrinkles, asymmetrical defects and conditions of the human skin, namely stretch marks, birthmarks, scarring, volume loss, and skin pigmentation diseases and disorders and for use in connection with the treatment of dermatitis, skin pigmentation diseases, skin wounds, bacterial skin infections, viral skin infections, parasitic skin infections, skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, eczema, rosacea, acne and psoriasis, for hydrating the skin during pregnancy, and preparations for cleaning the skin for medical use